In addition, Rapamycin was shown to attenuate heterotopic ossification in FOP mouse types [66], plus a Stage II medical trial for Rapamycin is at the moment ongoing. In summary, fast, and enjoyable advances are already made in our understating of FOP mechanism and drug progress. A number of opportun